|
|
| SC6A3_MACFA |
SLC6A3 |
Sodium-dependent dopamine transporter |
2.03e-40 |
0.31
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
2.831e-39 |
0.30
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
4.947e-35 |
0.48
|
| SC6A3_BOVIN |
SLC6A3 |
Sodium-dependent dopamine transporter |
6.147e-31 |
0.33
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
9.729e-28 |
0.41
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
8.378e-27 |
0.31
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
2.316e-26 |
0.35
|
| MRGX1_RAT |
Mrgprx1 |
Mas-related G-protein coupled receptor member X1 |
2.625e-26 |
0.30
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
7.184e-26 |
0.32
|
| Q8CGM4_CAVPO |
OPRM1 |
Mu-opioid receptor |
2.916e-24 |
0.36
|
| ADA2A_PIG |
ADRA2A |
Alpha-2A adrenergic receptor |
1.444e-23 |
0.29
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
4.518e-23 |
0.48
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
1.172e-21 |
0.37
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
1.172e-19 |
0.52
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
2.716e-18 |
0.36
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
3.644e-18 |
0.41
|
| Q4WLT4_ASPFU |
|
1,3-beta-glucan synthase catalytic subunit FksP |
7.773e-18 |
0.28
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.027e-17 |
0.47
|
| OPRD_MOUSE |
Oprd1 |
Delta-type opioid receptor |
1.156e-17 |
0.52
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
4.586e-17 |
0.40
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
1.11e-16 |
0.47
|
| Q9WTR4_RAT |
Slc6a2 |
Transporter |
2.22e-16 |
0.34
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
6.661e-16 |
0.29
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
5.44e-15 |
0.29
|
| O13428_CANAX |
GSC1 |
Beta-1,3-glucan synthase catalytic subunit 1 |
6.55e-15 |
0.28
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
1.699e-14 |
0.32
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
5.518e-14 |
0.31
|
| Q8QGU2_CHICK |
FKBP12.6 |
Peptidylprolyl isomerase |
7.405e-14 |
0.28
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
1.484e-13 |
0.38
|
| SC6A1_RAT |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
9.072e-13 |
0.29
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
3.125e-12 |
0.31
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
3.154e-12 |
0.43
|
| Q98UH1_DANRE |
oprm1 |
Mu opioid receptor-like OR2 |
8.327e-12 |
0.32
|
| MRGX1_HUMAN |
MRGPRX1 |
Mas-related G-protein coupled receptor member X1 |
9.195e-12 |
0.30
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
1.8e-11 |
0.29
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
2.947e-11 |
0.38
|
| Q95PM0_TRYBR |
rhodesain |
Cysteine protease |
5.116e-11 |
0.30
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
9.404e-11 |
0.42
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
1.082e-10 |
0.38
|
| LKHA4_HUMAN |
LTA4H |
Leukotriene A-4 hydrolase |
2.952e-10 |
0.36
|
| FKB1A_HUMAN |
FKBP1A |
Peptidyl-prolyl cis-trans isomerase FKBP1A |
9.792e-10 |
0.34
|
| Q8VH26_CAVPO |
GPM3 |
Muscarinic acetylcholine receptor |
1.036e-09 |
0.36
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.514e-09 |
0.34
|
| ACE_HUMAN |
ACE |
Angiotensin-converting enzyme |
1.821e-09 |
0.30
|
| SC6A3_HUMAN |
SLC6A3 |
Sodium-dependent dopamine transporter |
2.155e-09 |
0.34
|
| Q8WSF8_APLCA |
|
Soluble acetylcholine receptor |
4.592e-09 |
0.29
|
| PTR1_LEIMA |
PTR1 |
Pteridine reductase 1 |
1.37e-08 |
0.30
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.403e-08 |
0.39
|
| CAC1B_HUMAN |
CACNA1B |
Voltage-dependent N-type calcium channel subunit alpha-1B |
1.726e-08 |
0.31
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
3.275e-08 |
0.41
|
| Q7JHP9_MACMU |
SLC6A3 |
Transporter |
3.475e-08 |
0.33
|
| ACHP_LYMST |
|
Acetylcholine-binding protein |
7.966e-08 |
0.31
|
| ACM5_HUMAN |
CHRM5 |
Muscarinic acetylcholine receptor M5 |
9.67e-08 |
0.35
|
| AGTR2_RAT |
Agtr2 |
Type-2 angiotensin II receptor |
4.481e-07 |
0.36
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
5.425e-07 |
0.38
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
5.947e-07 |
0.30
|
| OPRM_MOUSE |
Oprm1 |
Mu-type opioid receptor |
9.55e-07 |
0.39
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.472e-06 |
0.37
|
| OPRX_CAVPO |
OPRL1 |
Nociceptin receptor |
2.611e-06 |
0.29
|
| CCR5_MACFA |
CCR5 |
C-C chemokine receptor type 5 |
4.993e-06 |
0.28
|
| TERA_HUMAN |
VCP |
Transitional endoplasmic reticulum ATPase |
5.376e-06 |
0.30
|
| T2R14_HUMAN |
TAS2R14 |
Taste receptor type 2 member 14 |
5.95e-06 |
0.32
|
| NMDE2_HUMAN |
GRIN2B |
Glutamate receptor ionotropic, NMDA 2B |
6.135e-06 |
0.32
|
| ACM4_HUMAN |
CHRM4 |
Muscarinic acetylcholine receptor M4 |
8.691e-06 |
0.35
|